Vaxart, Inc. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
Vaxart, Inc. (VXRT) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2026-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2025-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $1.00K.
- 2025-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $0.00 S-1 · filed 2026-05-08 |
| 2025-12-31 | $1.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 |
| 2024-12-31 | $8.00K S-1 · filed 2026-05-08 |
| 2024-09-30 | $27.00K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |